- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1084
Companies which are more than 50% undervalued based on analyst price target.
1084 companies
Aqua Metals
Market Cap: US$5.1m
Engages in reinventing metals recycling activities with its patented AquaRefining technology.
AQMS
US$3.88
7D
2.6%
1Y
-91.8%
Pineapple Financial
Market Cap: US$5.0m
Provides mortgage brokerage services and technology solutions to mortgage agents, brokers, sub-brokers, and brokerages and consumers in Canada.
PAPL
US$3.47
7D
-31.8%
1Y
-80.7%
Vision Marine Technologies
Market Cap: US$4.9m
Designs, develops, manufactures, rents, and sells electric boats in Canada, the United States, and internationally.
VMAR
US$1.56
7D
-2.5%
1Y
-99.4%
Revelation Biosciences
Market Cap: US$4.8m
Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.
REVB
US$2.79
7D
10.2%
1Y
-95.0%
Icon Energy
Market Cap: US$4.8m
A shipping company, providing seaborne transportation services for dry bulk cargoes through fleet of oceangoing vessels worldwide.
ICON
US$2.19
7D
2.8%
1Y
-97.8%
Creative Media & Community Trust
Market Cap: US$4.8m
As of March 31, 2025, our real estate portfolio consisted of 27 assets, all of which were fee-simple properties and five of which we own through investments in unconsolidated joint ventures (the “Unconsolidated Joint Ventures”).
CMCT
US$6.60
7D
-2.3%
1Y
-98.7%
Movano
Market Cap: US$4.6m
A technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices.
MOVE
US$0.69
7D
15.8%
1Y
-85.9%
Oragenics
Market Cap: US$4.6m
A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.
OGEN
US$1.12
7D
5.7%
1Y
-97.1%
Galecto
Market Cap: US$4.5m
A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
GLTO
US$3.36
7D
-0.4%
1Y
-75.9%
Quoin Pharmaceuticals
Market Cap: US$4.3m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$7.37
7D
4.6%
1Y
-65.2%
Aclarion
Market Cap: US$4.3m
Operates as a healthcare technology company in the United States.
ACON
US$7.21
7D
2.7%
1Y
-99.7%
Theriva Biologics
Market Cap: US$4.1m
A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.
TOVX
US$0.42
7D
-1.5%
1Y
-87.5%
Autonomix Medical
Market Cap: US$4.1m
A development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.
AMIX
US$1.16
7D
9.4%
1Y
-90.2%
Windtree Therapeutics
Market Cap: US$4.1m
A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.
WINT
US$0.10
7D
-78.6%
1Y
-100.0%
Silexion Therapeutics
Market Cap: US$4.0m
A biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
SLXN
US$7.20
7D
1.2%
1Y
-96.3%
Dermata Therapeutics
Market Cap: US$4.0m
A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.
DRMA
US$5.50
7D
-2.4%
1Y
-68.6%
Jaguar Health
Market Cap: US$3.9m
A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.
JAGX
US$1.76
7D
-8.3%
1Y
-94.0%
Bone Biologics
Market Cap: US$3.9m
A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.
BBLG
US$2.16
7D
-4.0%
1Y
-76.6%
GT Biopharma
Market Cap: US$3.9m
A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.
GTBP
US$1.14
7D
-14.3%
1Y
-49.1%
Biodexa Pharmaceuticals
Market Cap: US$3.8m
A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.
BDRX
US$5.58
7D
-18.8%
1Y
-96.2%
CNS Pharmaceuticals
Market Cap: US$3.8m
A clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors.
CNSP
US$6.12
7D
13.1%
1Y
-93.9%
Super League Enterprise
Market Cap: US$3.7m
Super League Enterprise, Inc. creates and publishes content experiences and media solutions across immersive platforms in the United States and internationally.
SLE
US$3.34
7D
-0.3%
1Y
-92.9%
Aethlon Medical
Market Cap: US$3.6m
A medical therapeutic company, focuses on developing products to treat cancer and life-threatening viral infectious, diseases in the United States.
AEMD
US$1.55
7D
37.2%
1Y
-59.3%
GRI Bio
Market Cap: US$3.6m
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.
GRI
US$1.41
7D
-0.7%
1Y
-85.7%
Beneficient
Market Cap: US$3.4m
A technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States.
BENF
US$0.42
7D
36.6%
1Y
-78.1%
Virax Biolabs Group
Market Cap: US$3.4m
A biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics.
VRAX
US$0.63
7D
-18.3%
1Y
-87.0%
ENDRA Life Sciences
Market Cap: US$3.3m
Develops technologies to improve the capabilities of clinical diagnostic ultrasound.
NDRA
US$4.09
7D
-11.9%
1Y
-77.0%
Digital Ally
Market Cap: US$3.2m
Produces and sells digital video imaging, storage, and disinfectant and related safety products for use in law enforcement, security, and commercial applications in the United States.
DGLY
US$1.82
7D
5.4%
1Y
-99.9%
Azitra
Market Cap: US$2.6m
An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.
AZTR
US$0.76
7D
-20.1%
1Y
-83.9%
CaliberCos
Market Cap: US$2.4m
A real estate investment, and an asset management firm specializes in middle-market assets.
CWD
US$1.72
7D
-5.5%
1Y
-86.3%
LogicMark
Market Cap: US$2.1m
Provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States.
LGMK
US$0.0035
7D
-7.9%
1Y
-99.9%
Formation Minerals
Market Cap: US$2.0m
Acquires and manages oil and gas minerals and royalties in the United States.
FOMI
US$0.02
7D
-20.0%
1Y
-61.1%
TPI Composites
Market Cap: US$1.7m
Manufactures and sells composite wind blades, and related precision molding and assembly systems to original equipment manufacturers (OEMs) in the United States, Mexico, Europe, the Middle East, Africa, and India.
TPIC.Q
US$0.034
7D
-24.4%
1Y
-99.2%
SpringBig Holdings
Market Cap: US$1.6m
Develops and operates a software platform that provides marketing and customer engagement services to cannabis dispensaries and brands in the United States and Canada.
SBIG
US$0.03
7D
20.0%
1Y
-53.9%
Unity Biotechnology
Market Cap: US$1.5m
A biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.
UNBX
US$0.081
7D
9.4%
1Y
-95.1%
Bio-Path Holdings
Market Cap: US$830.8k
Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.
BPTH
US$0.11
7D
0.9%
1Y
-90.3%